Greenfield Savings Bank’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-379
| Closed | -$240K | – | 151 |
|
|
2025
Q1 | $240K | Sell |
379
-112
| -23% | -$71K | 0.12% | 134 |
|
|
2024
Q4 | $350K | Sell |
491
-121
| -20% | -$86.2K | 0.17% | 117 |
|
|
2024
Q3 | $643K | Buy |
612
+136
| +29% | +$143K | 0.31% | 89 |
|
|
2024
Q2 | $500K | Buy |
476
+61
| +15% | +$64.1K | 0.26% | 93 |
|
|
2024
Q1 | $399K | Buy |
415
+123
| +42% | +$118K | 0.21% | 107 |
|
|
2023
Q4 | $256K | Buy |
292
+10
| +4% | +$8.78K | 0.15% | 122 |
|
|
2023
Q3 | $232K | Hold |
282
| – | – | 0.15% | 128 |
|
|
2023
Q2 | $203K | Hold |
282
| – | – | 0.14% | 134 |
|
|
2023
Q1 | $232K | Sell |
282
-25
| -8% | -$20.5K | 0.15% | 124 |
|
|
2022
Q4 | $221K | Hold |
307
| – | – | 0.15% | 124 |
|
|
2022
Q3 | $211K | Buy |
+307
| New | +$211K | 0.15% | 129 |
|